1,3-dipropyl-8-cyclopentylxanthine has been researched along with vecuronium bromide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breadon, EL; Lindsay, KE; Prior, C | 1 |
| Higa, K; Higuchi, H; Iihoshi, M; Nitahara, K; Shono, S; Vizi, ES | 1 |
2 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and vecuronium bromide
| Article | Year |
|---|---|
Modulation by presynaptic adenosine A1 receptors of nicotinic receptor antagonist-induced neuromuscular block in the mouse.
Topics: Adenine; Animals; Enzyme Inhibitors; Hexamethonium; Mice; Mice, Inbred BALB C; Neuromuscular Blockade; Neuromuscular Junction; Nicotinic Antagonists; Purinergic P1 Receptor Antagonists; Receptors, Presynaptic; Receptors, Purinergic P1; Tetany; Vecuronium Bromide; Xanthines | 1997 |
Reversal of neuromuscular effects of adenosine by specific adenosine A1-receptor antagonist in live rats.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Drug Interactions; Drug Synergism; Male; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Sciatic Nerve; Synaptic Transmission; Vecuronium Bromide; Xanthines | 2005 |